Abstract
Keywords
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to Journal of the Neurological SciencesReferences
Charcot JM. Lectures on the Diseases of the Nervous System. Second Series, Lecture VI (translated by G Sigerson), The New Sydenham Society, London, 1877.
- Initiation and progression of axonopathy in experimental autoimmune encephalomyelitis.J Neurosci. 2009; 29: 14965-14979
- T cells become licensed in the lung to enter the central nervous system.Nature. 2012; 488: 675-679
- C-C chemokine receptor 6-regulated entry of Th-17 cells into the CNS through the choroid plexus is required for the initiation of EAE.Nat Immunol. 2009; 10: 514-523
- Th17 lymphocytes traffic to the central nervous system independently of a4 integrin expression during EAE.J Exp Med. 2011; 208: 2465-2476
- Regional neural activation defines a gateway for autoreactive T cells to cross the blood–brain barrier.Cell. 2012; 148: 447-457
- Myelin oligodendrocyte glycoprotein-35-55 peptide induces severe chronic experimental autoimmune encephalomyelitis in HLA-DR2-transgenic mice.Eur J Immunol. 2004; 34: 1251-1261
- Induction of progressive demyelinating autoimmune encephalomyelitis in common marmoset monkeys using MOG34-56 peptide in incomplete Freund adjuvant.J Neuropathol Exp Neurol. 2010; 69: 372-385
- Heterogeneity of multiple sclerosis pathogenesis: implications for diagnosis and therapy.Trends Mol Med. 2001; 7: 115-121
- Axonal loss in multiple sclerosis: a pathological survey of the corticospinal and sensory tracts.Brain. 2004; 127: 1009-1018
- The neuropathological basis of clinical progression in multiple sclerosis.Acta Neuropathol. 2011; 122: 155-170
- Increased frequencies of myelin oligodendrocyte glycoprotein/MHC class II-binding CD4 cells in patients with multiple sclerosis.J Immunol. 2011; 187: 1039-1046
- Th17 cells in autoimmune demyelinating disease.SeminImmunopathol. 2010; 32: 71-77
- In vivo imaging of partially reversible Th17 cell-induced neuronal dysfunction in the course of encephalomyelitis.Immunity. 2010; 33: 424-436
- Antibody response in MOG35-55 induced EAE.J Neuroimmunol. 2011; 40–241: 28-33
- Antibodies to MOG are transient in childhood acute disseminated encephalomyelitis.Neurology. 2011; 77: 580-588
- Complement activating antibodies to myelin oligodendrocyte glycoprotein in neuromyelitisoptica and related disorders.J Neuroinflamm. 2011; 8: 184
- Myelin-oligodendrocyte glycoprotein antibodies in adults with neuromyelitisoptica phenotype.Neurology. 2012; 79: 1273-1277
- Early neuronal and glial fate restriction of embryonic neural stem cells.J Neurosci. 2008; 28: 2551-2562
- Local generation of glia is a major astrocyte source in postnatal cortex.Nature. 2012; 484: 376-380
- Macroglial plasticity and the origins of reactive astroglia in experimental autoimmune encephalomyelitis.J Neurosci. 2011; 31: 11914-11928
- Subventricular zone astrocytes are neural stem cells in the adult mammalian brain.Cell. 1999; 97: 703-716
- Astrogliosis in EAE spinal cord: derivation from radial glia, and relationships to oligodendroglia.Glia. 2007; 55: 57-64
- Molecular outcomes of neuromyelitisoptica (NMO)-IgG binding to aquaporin-4 in astrocytes.Proc Natl Acad Sci USA. 2012; 109: 1245-1250
- Proteomic analysis of active multiple sclerosis lesions reveals therapeutic targets.Nature. 2008; 451: 1076-1081
- Aquaporin-4 autoantibodies cause asymptomatic aquaporin-4 loss and activate astrocytes in mouse.J Neuroimmunol. 2012; 245: 32-38
- Greatly attenuated experimental autoimmune encephalomyelitis in aquaporin-4 knockout mice.BMC Neurosci. 2009; 10: 94
- Live astrocytes visualized by green fluorescent protein in transgenic mice.DevBiol. 1997; 187: 36-42
- Gage FH (2000) Proliferation and differentiation of progenitor cells throughout the intact adult rat spinal cord.J Neurosci. 2000; 20: 2218-2228
- Differentiation signals in the CNS: type-2 astrocyte development in vitro as a model system.Neuron. 1990; 5: 111-119
- Origin of new glial cells in intact and injured adult spinal cord.Cell Stem Cell. 2010; 7: 470-482
- The blood–brain barrier in health and chronic neurodegenerative disorders.Nature. 2008; 57: 178-201
- Inflammatory cell trafficking across the blood–brain barrier: chemokine regulation and in vitro models.Immunol Rev. 2012; 248: 228-239
- Astrocyte expression of mRNA encoding cytokines IP-10 and JE/MCP-1 in experimental autoimmune encephalomyelitis.FASEB J. 1993; 7: 592-600
- Resistance to experimental autoimmune encephalomyelitis in mice lacking the CC chemokine receptor (CCR)2.J Exp Med. 2000; 192: 1075-1080
- Absence of monocyte chemoattractant protein 1 in mice leads to decreased local macrophage recruitment and antigen-specific T helper cell type 1 immune response in experimental autoimmune encephalomyelitis.J Exp Med. 2001; 193: 713-726
- Infiltrating monocytes trigger EAE progression but do not contribute to the resident microglia pool.Nature Neurosci. 2011; 14: 1142-1149
- Review: The chemokine receptor CXCR3 and its ligands CXCL9, CXCL10 and CXCL11 in neuroimmunity – a tale of conflict and conundrum.Neuropathol Appl Neurobiol. 2010; 36: 368-387
- Hyaluronan accumulates in demyelinated lesions and inhibits oligodendrocyte progenitor maturation.Nature Med. 2005; 11: 966-972
- Remyelination is altered by bone morphogenic protein signaling in demyelinated lesions.J Neurosci. 2011; 31: 4504-4510
- Glutamate metabolism is down-regulated in astrocytes during experimental allergic encephalomyelitis.Glia. 1997; 20: 79-85
- Altered expression of glutamate transporters in experimental autoimmune encephalomyelitis.J Neuroimmunol. 2002; 125: 170-178
- GluR2-free alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionate receptors intensify demyelination in experimental autoimmune encephalomyelitis.J Neurochem. 2007; 102: 1064-1070
- Glutamate receptors on myelinated spinal cord axons: II. AMPA and GluR5 receptors.Ann Neurol. 2009; 65: 160-166
- Disruption of NMDA receptors in oligodendroglial lineage cells does not alter their susceptibility to experimental autoimmune encephalomyelitis or their normal development.J Neurosci. 2012; 32: 639-645
- Astrocytes are active players in cerebral innate immunity.Trends Immunol. 2007; 28: 138-145
- Transgenic inhibition of astroglial NF-B improves functional outcome in experimental autoimmune encephalomyelitis by suppressing chronic central nervous system inflammation.J Immunol. 2009; 182: 2628-2640
- CNS-specific therapy for ongoing EAE by silencing IL-17 pathway in astrocytes.Mol Ther. 2012; 20: 1338-1348
- Stimulation of the neurotrophin receptor TrkB on astrocytes drives nitric oxide production and neurodegeneration.J Exp Med. 2012; 209: 521-535
- Gp130-dependentastrocytic survival is critical for control of autoimmune central nervous system inflammation.J Immunol. 2011; 186: 6521-6531
Article info
Publication history
Footnotes
☆Supported by grants from Shriners Hospitals for Children, the National Multiple Sclerosis Foundation, US Army Medical Research, and NINDS.
☆☆Dedication: To Bob Lisak, who introduced DP to neuroimmunology during commutes to and from the University of Pennsylvania.